ArticleFrontiers in immunology2020

T-Cell Therapeutics Targeting Human Parainfluenza Virus 3 Are Broadly Epitope Specific and Are Cross Reactive With Human Parainfluenza Virus 1.

Katherine M Harris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.